These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19364285)

  • 1. Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liver.
    Jager L; Ehrhardt A
    Hum Gene Ther; 2009 Aug; 20(8):883-96. PubMed ID: 19364285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into stability of recombinant adenovirus vector genomes in mammalian cells.
    Rauschhuber C; Noske N; Ehrhardt A
    Eur J Cell Biol; 2012 Jan; 91(1):2-9. PubMed ID: 21440326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction.
    Puntel M; Curtin JF; Zirger JM; Muhammad AK; Xiong W; Liu C; Hu J; Kroeger KM; Czer P; Sciascia S; Mondkar S; Lowenstein PR; Castro MG
    Hum Gene Ther; 2006 May; 17(5):531-44. PubMed ID: 16716110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication and packaging of helper-dependent adenoviral vectors.
    Sato M; Suzuki S; Kubo S; Mitani K
    Gene Ther; 2002 Apr; 9(7):472-6. PubMed ID: 11938462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors.
    Kreppel F; Kochanek S
    J Virol; 2004 Jan; 78(1):9-22. PubMed ID: 14671083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes.
    Marienfeld U; Haack A; Thalheimer P; Schneider-Rasp S; Brackmann HH; Poller W
    Gene Ther; 1999 Jun; 6(6):1101-13. PubMed ID: 10455413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
    Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
    Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid protocol for construction and production of high-capacity adenoviral vectors.
    Jager L; Hausl MA; Rauschhuber C; Wolf NM; Kay MA; Ehrhardt A
    Nat Protoc; 2009; 4(4):547-64. PubMed ID: 19373227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles.
    Murakami P; Pungor E; Files J; Do L; van Rijnsoever R; Vogels R; Bout A; McCaman M
    Hum Gene Ther; 2002 May; 13(8):909-20. PubMed ID: 12031124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue, amplification, purification, and PEGylation of replication defective first-generation adenoviral vectors.
    Barry MA; Weaver EA; Hofherr SE
    Methods Mol Biol; 2010; 651():227-39. PubMed ID: 20686969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication.
    Nelson JE; Kay MA
    J Virol; 1997 Nov; 71(11):8902-7. PubMed ID: 9343256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of high-capacity adenovirus production by the quantitative real-time polymerase chain reaction: a comparative study of different titration methods.
    Crettaz J; Olague C; Vales A; Aurrekoetxea I; Berraondo P; Otano I; Kochanek S; Prieto J; González-Aseguinolaza G
    J Gene Med; 2008 Oct; 10(10):1092-101. PubMed ID: 18642400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle.
    Jiang ZL; Reay D; Kreppel F; Gambotto A; Feingold E; Kochanek S; McCarthy SA; Clemens PR
    Mol Ther; 2001 Jun; 3(6):892-900. PubMed ID: 11407903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient genome replication of hepatitis B virus using adenovirus vector: a compact pregenomic RNA-expression unit.
    Suzuki M; Kondo S; Yamasaki M; Matsuda N; Nomoto A; Suzuki T; Saito I; Kanegae Y
    Sci Rep; 2017 Feb; 7():41851. PubMed ID: 28157182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
    Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA
    Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-capacity 'gutless' adenoviral vectors.
    Kochanek S; Schiedner G; Volpers C
    Curr Opin Mol Ther; 2001 Oct; 3(5):454-63. PubMed ID: 11699889
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Komatsu T; Quentin-Froignant C; Carlon-Andres I; Lagadec F; Rayne F; Ragues J; Kehlenbach RH; Zhang W; Ehrhardt A; Bystricky K; Morin R; Lagarde JM; Gallardo F; Wodrich H
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications.
    Barcia C; Jimenez-Dalmaroni M; Kroeger KM; Puntel M; Rapaport AJ; Larocque D; King GD; Johnson SA; Liu C; Xiong W; Candolfi M; Mondkar S; Ng P; Palmer D; Castro MG; Lowenstein PR
    Mol Ther; 2007 Dec; 15(12):2154-63. PubMed ID: 17895861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.